Share this article
Share this article
SUNNYVALE, Calif., Feb. 19, 2021 /PRNewswire/ Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Byron C. Scott, M.D., MBA to the company s Board of Directors, effective as of February 12, 2021. Dr. Scott brings significant experience as a physician executive with invaluable global expertise in healthcare analytics and technology.
Dr. Scott is currently on the faculties at the University of Massachusetts, Amherst, Isenberg School of Management and Jefferson University, College of Population Health where he teaches healthcare quality, patient safety, and performance improvement. Previously, Dr. Scott served as Deputy Chief Health Officer at IBM Watson Health, where he successfully guided healthcare organizations in the alignment of strategies, quality and performance improvement, and was an industry-recognized thought leader with respect to Watson Health products and services. Dr. Scott also held leadership roles at Truven
Wicked Local
Accountant and local mom Rebecca Stronck is running for one of two seats on the North Andover School Committee, a campaign she says was ignited by the current COVID-19 crisis and related school closures.
“The seed was planted in my mind when I watched my own children’s academic spirit start to deteriorate under the current method,” Stronck said.
Her children Emily, age 10, and Gabriel, age 8 are in fifth grade and third grade, respectively, and they’re in the district’s hybrid learning model attending school some days and having remote learning on others.
“My children love school. They love to learn. They love to be there,” Stronck said. “Socially, emotionally and academically, they weren’t getting challenged and weren’t getting pushed forward to the extent that we wanted them to be.”
The spoilage of nearly 2,000 COVID-19 vaccines at the VA Medical Center in Boston’s Jamaica Plain neighborhood sparked a reaction from people in the city..
Dynavax Appoints Kelly MacDonald as Chief Financial Officer
News provided by
Share this article
Share this article
EMERYVILLE, Calif., Jan. 20, 2021 /PRNewswire/ Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Kelly MacDonald has been appointed Senior Vice President and Chief Financial Officer. Ms. MacDonald will join the company effective March 1, 2021.
As previously announced, after 14 years at Dynavax, Chief Financial Officer Michael Ostrach is retiring. Mr. Ostrach has agreed to remain available as an advisor to the Company thereafter.
Dynavax Appoints Kelly MacDonald as Chief Financial Officer Michael s contributions and unwavering commitment to Dynavax have been critical to the success of our company. We are extremely fortunate to have had his guidance over the years and now as a strategic advisor to ensure a seamless transition to his successor, commented Ryan Spe
Theresa Curry Named Interim Vice Chancellor for Advancement in Amherst
January 12, 2021
Theresa Curry
University of Massachusetts Amherst Vice Chancellor for Advancement Mark Fuller has been named interim chancellor of UMass Dartmouth effective Jan. 19, 2021.
Chancellor Kumble Subbaswamy praised Fuller’s 12 years of service at UMass Amherst and also announced that Theresa Curry, associate vice chancellor for development and executive director of gift planning at the Amherst campus, has been named interim vice chancellor for advancement.
Fuller has led the university’s advancement efforts since 2018, establishing a strong foundation for UMass Amherst’s upcoming capital campaign. Previously, he served as dean of the Isenberg School of Management for nine transformative years, helping elevate Isenberg into one of the top business management programs in the country.